Mon. 6 May 2024, 4:27pm ET
Benzinga
Earnings, Earnings Beats, News
Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 12.12 percent increase over losses of $(0.33) per share from the same period last year.